Patients with dry eye associated with Sjogren'
Conditions
Interventions
Mucosta ophthalmic suspension UD2%
Sponsors
Kanazawa Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.20 years old or older(female or male). 2.Patients who are clinically diagnosed as dry eye and Sjogren's syndrome. 3.At the start of study examination, i)Fluorescein corneal staining score of 3 greater.(9 point full marks) ii)Lissamine green conjunctival staining score of 3 greater.(6 point full marks) 4.Outpatient or hospitalization. 5.Patients who can obtain written informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients with concomitant anterior eye disease other than dry eye. 2.Patients who have used rebamipide ophthalmic suspension within two weeks prior to the start of the study. 3.Patients who are anticipated to change their eye drop (prescription or OTC medication) during the study. 4.Patients who cannot discontinue use of contact lenses during the study. 5.Patients who inserted punctal plugs or underwent surgical punctal occlusion within one month. 6.Patients who are pregnant, suspected to be pregnant or breastfeeding. 7.Patients who are hypersensitive to the ingredients of the study drug and/or test reagents for this study. 8.Patients who are judged to be ineligible for the study for complications and/or history of systemic disease. 9.Patients who are considered to be inapproriate by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Fluorescein corneal staining score. 2.Lissamine green conjunctival staining score. | — |
Countries
Japan
Contacts
Public ContactKazuko Kitagawa
Kanazawa Medical University Department of Ophthalmology
Outcome results
None listed